What does Bio-Path Holdings, Inc. do?

Jun 22 2025 06:20 PM IST
share
Share Via
Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology-focused company specializing in antisense drug development, with a market cap of USD 1.66 million and a recent net profit of -3 million. The company has no dividend yield and is currently loss-making.
Overview:
Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company in the Pharmaceuticals & Biotechnology industry with a market cap of USD 1.66 Million.

Financial Snapshot:
Most recent Net Profit: -3 Million (Quarterly Results - Mar 2025)
Market-cap: USD 1.66 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.07
Return on Equity: 436.93%
Price to Book: -0.64

Contact Details:
Address: 4710 Bellaire Blvd Ste 210, BELLAIRE TX : 77401-4505
Tel: ['1 832 7421357', '1 832 7421369']
Website: http://www.biopathholdings.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Bio-Path Holdings, Inc. technically bullish or bearish?
Sep 20 2025 07:22 PM IST
share
Share Via
Is Bio-Path Holdings, Inc. overvalued or undervalued?
Jun 25 2025 08:35 AM IST
share
Share Via
Is Bio-Path Holdings, Inc. technically bullish or bearish?
Jun 25 2025 08:30 AM IST
share
Share Via
Who are in the management team of Bio-Path Holdings, Inc.?
Jun 22 2025 10:16 PM IST
share
Share Via